Cargando…

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France

INTRODUCTION: Geographical variation in the prevalence of multiple sclerosis (MS) is controversial. Heterogeneity is important to acknowledge to adapt the provision of care within the healthcare system. We aimed to investigate differences in prevalence of MS in departments in the French territory. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivot, Diane, Debouverie, Marc, Grzebyk, Michel, Brassat, David, Clanet, Michel, Clavelou, Pierre, Confavreux, Christian, Edan, Gilles, Leray, Emmanuelle, Moreau, Thibault, Vukusic, Sandra, Hédelin, Guy, Guillemin, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147922/ https://www.ncbi.nlm.nih.gov/pubmed/27936086 http://dx.doi.org/10.1371/journal.pone.0167556

Ejemplares similares

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
por: Leray, Emmanuelle, et al.
Publicado: (2015)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
por: Tourbah, Ayman, et al.
Publicado: (2016)

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
por: Wilson, Sarah, et al.
Publicado: (2022)

A case report of simultaneous PML-IRIS during corticosteroids tapering in a patient with an anti-synthetase syndrome
por: Martin-Blondel, Guillaume, et al.
Publicado: (2013)

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
por: Laplaud, David-Axel, et al.
Publicado: (2019)

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort
por: Papeix, Caroline, et al.
Publicado: (2016)

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data
por: Foulon, Stéphanie, et al.
Publicado: (2017)

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament‐light chain in multiple sclerosis
por: Gauthier, Audrey, et al.
Publicado: (2021)

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
por: Tourbah, Ayman, et al.
Publicado: (2018)

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
por: Barbin, Laetitia, et al.
Publicado: (2016)

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France
por: Gbaguidi, Brigitte, et al.
Publicado: (2022)

Evidence for a two-stage disability progression in multiple sclerosis
por: Leray, Emmanuelle, et al.
Publicado: (2010)

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
por: Papeix, Caroline, et al.
Publicado: (2022)

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
por: Manceau, Philippe, et al.
Publicado: (2014)

Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France
por: Guilleux, Alice, et al.
Publicado: (2020)

Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study
por: Nardin, Clotilde, et al.
Publicado: (2018)

Disability progression in multiple sclerosis patients using early first‐line treatments
por: Lefort, Mathilde, et al.
Publicado: (2022)

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers
por: Hammas, Karima, et al.
Publicado: (2017)

DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Effect of occupational safety and health education received during schooling on the incidence of workplace injuries in the first 2 years of occupational life: a prospective study
por: Boini, Stephanie, et al.
Publicado: (2017)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
por: Edan, Gilles, et al.
Publicado: (2023)

Pregnancy-related healthcare utilization among women with multiple sclerosis
por: Mainguy, Marie, et al.
Publicado: (2023)

Methodology for building a geographical accessibility health index throughout metropolitan France
por: Launay, Ludivine, et al.
Publicado: (2019)

No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks’ Outcome?
por: Fayet, Yohan, et al.
Publicado: (2022)

Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
por: Turpin, Anthony, et al.
Publicado: (2019)

Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France
por: Marty, Lise, et al.
Publicado: (2018)

Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program
por: Fayet, Yohan, et al.
Publicado: (2018)

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis
por: Couloume, Laura, et al.
Publicado: (2021)

No evidence for XMRV association in pediatric idiopathic diseases in France
por: Jeziorski, Eric, et al.
Publicado: (2010)

Data on 2341 grass fields from 100 mountain-area dairy farms in France: Agricultural uses and geographical characteristics
por: Sibra, Cécile, et al.
Publicado: (2023)

The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
por: Metzger-Peter, Katline, et al.
Publicado: (2020)

Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase
por: Cochet, Amandine, et al.
Publicado: (2022)

Sites de France /
por: Braive, Michel François
Publicado: (1950)

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome
por: Maillart, Elisabeth, et al.
Publicado: (2017)

Socioeconomic and geographic determinants of survival of patients with digestive cancer in France
por: Dejardin, O, et al.
Publicado: (2006)

Geographical variation in the heterogeneity of mutualistic networks
por: Sakai, Shoko, et al.
Publicado: (2016)

Aspectos del cine francés
por: Michel, Manuel
Publicado: (1964)

Restricted diversity of dental calculus methanogens over five centuries, France
por: Huynh, Hong T. T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l4tenee1m8pk636gimh73icle9